Compound class
Cognitive and sleep peptides
Neuropeptides, a sleep peptide and a few oral compounds.
Semax is a synthetic heptapeptide analog of the ACTH 4-10 fragment,1 selank is a synthetic analog of the endogenous tuftsin molecule,2 and DSIP (emideltide) is a synthetic nonapeptide.3 FDA's 2026 briefing found no pharmacokinetic study of semax in humans, proposed not adding semax to the 503A bulks list for compounding, and raised concerns about immunogenicity and a possible risk of bleeding.1 Other members are oral drugs, such as armodafinil, which its US label calls a wakefulness-promoting agent.4
Compounds in this class 16
-
Semax
Neuropeptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Adamax
Nootropic peptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Armodafinil
Wakefulness-Promoting agent
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- Has a US label
-
Bromantane
Actoprotector
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Cerebrolysin
Neuropeptide complex
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Dihexa
Neuropeptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
DSIP (Delta Sleep-Inducing Peptide)
Sleep peptide
- Half-life
- 8 minutes
- Given
- Not stated
- Form or status
- No product label among its sources
-
Methylene Blue
Mitochondrial electron carrier
- Half-life
- About 24 hours (IV, ProvayBlue label)
- Given
- One IV dose, repeated after one hour if needed (ProvayBlue label)
- Form or status
- US label for ProvayBlue, an IV injection
-
Noopept
Nootropic
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Oxytocin
Neuropeptide
- Half-life
- About 1 to 6 minutes
- Given
- Not stated
- Form or status
- Has a US label
-
P021
Neurotrophic peptidomimetic
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
PE-22-28
Neuropeptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Phenylpiracetam Hydrazide
Racetam derivative
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- Not stated
-
Pinealon
Neuropeptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Selank
Neuropeptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Semax + Selank
Blend
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
Half-lives side by side
The figure each source gives, on one scale. Bars are ranges.
- Oxytocinabout 1 to 6 min
- DSIP (Delta Sleep-Inducing Peptide)8 min
- Methylene Blueabout 24 h, IV
Log scale, 1 minute to about 3 weeks. Each figure and its source are in the list above. Minutes, days and weeks are turned into hours (1 day is 24 hours) only to place them on the scale. These are the sources' figures; the half-life the app uses to draw levels can differ.
Guides 10
- Adamax dosage: mixing and syringe unitsNo label or trial gives an Adamax dose. The Semax figures sources report, and example mixes worked in units on a U-100 syringe.
- Dihexa dosage: what sources saySearches found no dihexa label or human trial dose. The rat paper giving 2 mg/kg a day by mouth was retracted in 2025. What FDA and animal studies report.
- DSIP dosage: mixing and units per doseWhat FDA and the human trials give for DSIP dose and schedule, and the vial and syringe maths for a 5 mg powder, with no label and no subcutaneous trial.
- How to take oxytocin: what sources sayNasal oxytocin doses from two trials, injection label strengths and routes, one subcutaneous trial and storage conditions, each with its source.
- How to take pinealon: mixing and syringe unitsThe only pinealon dose in the human reports found, why no vial strength or syringe mark can be sourced, and what is not known about mixing and storage.
- How to take selank: nasal-drop label and logged vial setupsThe Russian label dose for selank nasal drops, a trial dose, and syringe arithmetic for 10 mg vials mixed with 2 or 3 mL, as logged in Milligram.
- How to use Cerebrolysin: what sources sayMaker's daily doses and routes for Cerebrolysin, the doses stroke, dementia and brain injury trials gave, ampoule strength, syringe units and storage.
- P021 dosage: what sources saySearches returned no label or human dose for p021. Mouse studies gave 60 nmol per g of diet or 750 nmol per mouse; a table lists each.
- Semax and selank dosage: nasal-drop labels and logged vialsLabel doses for semax and selank nasal drops, semax trial doses, what Milligram users log, and how a 10 mg vial maps to syringe marks.
- Semax dosage: nasal-drop label, studies and logged vialsSemax doses from the Russian label and human trials, a vial and water table with U-100 syringe marks for 10 mg and 5 mg vials, and storage.
Calculators 1
Compare 1
Logged in Milligram
Share of people who logged a dose in Milligram in the 90 days to 15 November 2026 who logged each compound.
Semax, how often
How often: among people with three or more logged doses, by the average gap between their doses.
Aggregated and anonymous, shares of people only. Each compound not listed: too few people logged it to show a share. It describes what people set up in the app, not advice on what to take.
References 7
- US Food and Drug Administration. Evaluation of Semax-related bulk drug substances (Semax (free base) and Semax acetate) for inclusion on the 503A bulk drug substances list. FDA briefing document, Pharmacy Compounding Advisory Committee, July 23-24, 2026 (dated 5/11/2026). 2026. fda.gov
- Volkova A, Shadrina M, Kolomin T, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. 2016. PMC4757669
- U.S. Food and Drug Administration. FDA presentation on emideltide-related bulk drug substances, Pharmacy Compounding Advisory Committee, 24 July 2026. 2026. fda.gov
- Cephalon, LLC. Nuvigil (armodafinil) label, version 32. 2022. DailyMed label
- U.S. Food and Drug Administration. FDA Evaluation of Emideltide-Related Bulk Drug Substances (Emideltide (free base) and Emideltide acetate). Briefing document for the Pharmacy Compounding Advisory Committee meeting of 23-24 July 2026, dated 11 May 2026. FDA evaluation
- American Regent, Inc. ProvayBlue (methylene blue) injection. US prescribing information, DailyMed record version 28, 2025. DailyMed label
- Par Health USA, LLC. Pitocin (oxytocin injection, USP) prescribing information. DailyMed 2026. DailyMed label
Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.